相关实验视频

Updated: Jul 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

无细胞DNA基因组分析及其在晚期前列腺癌中临床实施

Ivana Bratic Hench1, Luca Roma1, Floriana Conticelli1,2

  • 1Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.

Cancers
|January 11, 2024
PubMed
概括

这项研究表明,循环瘤DNA (ctDNA) 的目标下一代测序 (NGS) 可以检测出关键前列腺癌 (PCa) 突变. 这种液体活检方法有助于指导晚期前列腺癌的个性化治疗.

关键词:
在循环中循环的无细胞DNA.液体活检活检液体活检这是下一代测序.精准医学是一门精准医学.前列腺癌是前列腺癌.

更多相关视频

Cell-Free DNA Integrity Analysis in Urine Samples07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

13.8K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...